A detailed history of Jpmorgan Chase & CO transactions in Royalty Pharma PLC stock. As of the latest transaction made, Jpmorgan Chase & CO holds 7,739,281 shares of RPRX stock, worth $211 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,739,281
Previous 7,995,099 3.2%
Holding current value
$211 Million
Previous $243 Million 15.95%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$26.26 - $29.9 $6.72 Million - $7.65 Million
-255,818 Reduced 3.2%
7,739,281 $204 Million
Q1 2024

May 10, 2024

SELL
$27.46 - $31.33 $19.4 Million - $22.1 Million
-705,220 Reduced 8.11%
7,995,099 $243 Million
Q4 2023

Feb 12, 2024

SELL
$26.21 - $29.22 $4.91 Million - $5.47 Million
-187,248 Reduced 2.11%
8,700,319 $244 Million
Q3 2023

Nov 14, 2023

BUY
$26.26 - $31.38 $3.98 Million - $4.75 Million
151,396 Added 1.73%
8,887,567 $241 Million
Q2 2023

Aug 11, 2023

BUY
$29.6 - $36.56 $1.91 Million - $2.36 Million
64,608 Added 0.75%
8,736,171 $269 Million
Q1 2023

May 18, 2023

BUY
$32.77 - $39.4 $502,036 - $603,608
15,320 Added 0.18%
8,671,563 $312 Million
Q1 2023

May 11, 2023

BUY
$32.77 - $39.4 $7.59 Million - $9.12 Million
231,496 Added 2.75%
8,656,243 $312 Million
Q4 2022

Feb 13, 2023

BUY
$39.17 - $44.04 $3.65 Million - $4.1 Million
93,150 Added 1.12%
8,424,747 $333 Million
Q3 2022

Nov 14, 2022

BUY
$39.88 - $44.65 $27.3 Million - $30.5 Million
683,612 Added 8.94%
8,331,597 $335 Million
Q2 2022

Aug 11, 2022

BUY
$37.53 - $44.22 $78.4 Million - $92.4 Million
2,088,597 Added 37.57%
7,647,985 $322 Million
Q1 2022

May 11, 2022

BUY
$37.46 - $42.44 $5.14 Million - $5.82 Million
137,185 Added 2.53%
5,559,388 $217 Million
Q4 2021

Feb 10, 2022

BUY
$35.17 - $42.48 $3.72 Million - $4.49 Million
105,721 Added 1.99%
5,422,203 $216 Million
Q3 2021

Nov 12, 2021

BUY
$36.14 - $42.24 $192 Million - $225 Million
5,316,482 New
5,316,482 $192 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.9B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.